Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
Pathfinder Medical has raised $11.6M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Pathfinder Medical's investors include Business Growth Fund, Parkwalk Advisors, Deepbridge Capital, Cambridge Angels group, Andreas Cser.
Pathfinder Medical is headquartered in London, United Kingdom.
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
Pathfinder Medical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pathfinder Medical — Funding & Investors." VCBacked, January 20, 2022, https://www.vcbacked.co/company/pathfinder-medical. Accessed October 29, 2026.
VCBacked. (2022). Pathfinder Medical — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/pathfinder-medical
{{cite web |title=Pathfinder Medical — Funding & Investors |url=https://www.vcbacked.co/company/pathfinder-medical |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated